Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (647)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
299
12.590
 Why?
Papillomavirus Infections
19
2025
172
2.870
 Why?
Ovarian Neoplasms
37
2024
460
2.710
 Why?
Endometrial Neoplasms
34
2019
144
2.330
 Why?
Uterine Cervical Dysplasia
16
2017
51
2.320
 Why?
Carcinoma, Squamous Cell
31
2018
331
1.960
 Why?
Gene Expression Regulation, Neoplastic
19
2025
857
1.850
 Why?
Human papillomavirus 16
8
2019
44
1.670
 Why?
Papillomaviridae
17
2025
105
1.560
 Why?
Female
191
2025
28262
1.520
 Why?
Gene Expression Profiling
9
2021
1110
1.470
 Why?
DNA Methylation
22
2025
592
1.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
1031
1.250
 Why?
Genital Neoplasms, Female
10
2018
49
1.150
 Why?
Human papillomavirus 18
5
2019
9
1.140
 Why?
Humans
194
2025
52593
1.120
 Why?
Genetic Predisposition to Disease
14
2024
528
1.080
 Why?
Adult
92
2024
14170
1.040
 Why?
Neoplasm Staging
41
2019
768
1.000
 Why?
Middle Aged
99
2024
13096
0.980
 Why?
Adenocarcinoma
18
2018
404
0.970
 Why?
Polymorphism, Single Nucleotide
10
2019
506
0.930
 Why?
Fluorodeoxyglucose F18
15
2022
188
0.920
 Why?
DNA-Binding Proteins
9
2021
426
0.910
 Why?
MicroRNAs
7
2019
388
0.900
 Why?
Neoplasm Recurrence, Local
19
2024
643
0.890
 Why?
Carcinoma
12
2010
137
0.880
 Why?
Oncogene Proteins, Viral
4
2019
54
0.820
 Why?
Radiopharmaceuticals
14
2022
205
0.770
 Why?
Cervix Uteri
7
2017
49
0.770
 Why?
Repressor Proteins
4
2019
154
0.770
 Why?
Alphapapillomavirus
1
2021
13
0.730
 Why?
DNA, Viral
6
2019
138
0.710
 Why?
Cell Line, Tumor
18
2021
1436
0.700
 Why?
Immunologic Factors
2
2014
117
0.690
 Why?
Neoplasm Invasiveness
15
2020
278
0.670
 Why?
Neoplasms
8
2022
1308
0.650
 Why?
Genes, Tumor Suppressor
8
2007
73
0.650
 Why?
Genetic Markers
8
2017
109
0.650
 Why?
Neoplasm Proteins
10
2019
328
0.640
 Why?
Immunoglobulins
3
2017
76
0.630
 Why?
Aged
70
2024
10191
0.630
 Why?
Genomics
4
2018
270
0.620
 Why?
Gene Silencing
5
2018
120
0.600
 Why?
Biomedical Research
1
2022
258
0.590
 Why?
Vascular Endothelial Growth Factor A
2
2017
187
0.540
 Why?
Cisplatin
7
2022
285
0.530
 Why?
Proteomics
1
2019
327
0.520
 Why?
Promoter Regions, Genetic
12
2020
474
0.510
 Why?
Aged, 80 and over
36
2024
3420
0.500
 Why?
HLA-C Antigens
2
2018
5
0.500
 Why?
Receptors, KIR
2
2018
12
0.500
 Why?
Lymph Nodes
10
2010
252
0.480
 Why?
Positron-Emission Tomography
11
2013
303
0.480
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.480
 Why?
Tumor Virus Infections
4
2006
48
0.480
 Why?
Microsatellite Repeats
14
2007
42
0.470
 Why?
Alleles
6
2025
278
0.470
 Why?
Disease-Free Survival
17
2013
464
0.470
 Why?
Hysterectomy
15
2022
91
0.460
 Why?
Gynecologic Surgical Procedures
4
2010
29
0.460
 Why?
Virus Integration
3
2025
9
0.460
 Why?
Granulosa Cell Tumor
2
2024
3
0.450
 Why?
Phenotype
5
2016
800
0.440
 Why?
Prognosis
19
2021
2118
0.430
 Why?
Lymphatic Metastasis
14
2019
211
0.430
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.420
 Why?
Immunohistochemistry
13
2024
984
0.420
 Why?
Nuclear Proteins
8
2009
247
0.420
 Why?
Loss of Heterozygosity
10
2007
78
0.410
 Why?
Ovary
2
2008
107
0.400
 Why?
Membrane Proteins
3
2005
337
0.390
 Why?
Genotype
9
2018
571
0.380
 Why?
Survival Analysis
14
2021
673
0.380
 Why?
STAT3 Transcription Factor
3
2021
87
0.380
 Why?
Cell Movement
5
2021
276
0.380
 Why?
Ultrasonic Therapy
3
2001
30
0.370
 Why?
Peritoneal Neoplasms
4
2008
65
0.370
 Why?
Carcinoma, Endometrioid
6
2014
38
0.370
 Why?
Genes, p53
2
2010
52
0.370
 Why?
Cell Proliferation
6
2021
1029
0.360
 Why?
Uterine Neoplasms
5
2009
59
0.350
 Why?
Risk Factors
13
2019
3952
0.350
 Why?
Signal Transduction
8
2021
1714
0.350
 Why?
Mutation
12
2018
1344
0.340
 Why?
Carboplatin
2
2009
57
0.340
 Why?
Ascites
2
2008
32
0.340
 Why?
Antibodies, Monoclonal
5
2021
478
0.340
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
12
0.330
 Why?
Antineoplastic Agents
9
2014
1221
0.330
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
13
0.330
 Why?
Cohort Studies
13
2024
1553
0.330
 Why?
Base Sequence
8
2019
637
0.330
 Why?
Membrane Glycoproteins
2
2009
242
0.330
 Why?
GTPase-Activating Proteins
1
2009
25
0.320
 Why?
Disease Progression
6
2020
873
0.320
 Why?
DNA, Neoplasm
11
2006
146
0.320
 Why?
Chromosomes, Human, Pair 11
3
2005
55
0.310
 Why?
Matrix Metalloproteinase 9
1
2009
87
0.310
 Why?
Neoplasms, Glandular and Epithelial
3
2006
42
0.310
 Why?
Brachytherapy
9
2014
51
0.310
 Why?
Combined Modality Therapy
11
2010
639
0.310
 Why?
Proto-Oncogene Proteins c-myc
2
2021
53
0.310
 Why?
Abdominal Neoplasms
1
2009
16
0.310
 Why?
Genome, Human
3
2025
121
0.300
 Why?
Laser Coagulation
1
2009
27
0.300
 Why?
DNA Repair
11
2007
196
0.300
 Why?
Retrospective Studies
33
2024
6671
0.300
 Why?
Drug Administration Schedule
10
2013
376
0.300
 Why?
Homeodomain Proteins
2
2006
81
0.290
 Why?
Deoxycytidine
4
2006
29
0.290
 Why?
RNA-Binding Proteins
2
2021
134
0.290
 Why?
Protozoan Proteins
1
2008
32
0.290
 Why?
Microsatellite Instability
5
2019
21
0.290
 Why?
Germ-Line Mutation
3
2024
66
0.290
 Why?
Laparoscopy
3
2022
181
0.290
 Why?
Kaplan-Meier Estimate
6
2019
485
0.280
 Why?
Ovariectomy
7
2010
113
0.280
 Why?
Drug Resistance, Neoplasm
6
2016
327
0.270
 Why?
Antigens, CD
2
2007
216
0.270
 Why?
Heart Arrest
1
2009
137
0.270
 Why?
Chromosomes, Human, Pair 3
4
2001
18
0.270
 Why?
SOXC Transcription Factors
2
2019
13
0.270
 Why?
Polymerase Chain Reaction
9
2010
460
0.270
 Why?
Receptors, Estrogen
3
2024
132
0.260
 Why?
Topotecan
5
2013
17
0.260
 Why?
POU Domain Factors
1
2006
1
0.260
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.250
 Why?
Vulvar Neoplasms
5
2002
60
0.250
 Why?
Neoplasm Metastasis
5
2021
239
0.250
 Why?
HeLa Cells
3
2021
261
0.250
 Why?
Anemia
3
2020
74
0.240
 Why?
Genome, Viral
2
2025
83
0.240
 Why?
Registries
6
2010
629
0.240
 Why?
Survival Rate
10
2009
952
0.240
 Why?
Breast Neoplasms
5
2018
1205
0.240
 Why?
Vaginal Smears
6
2006
28
0.240
 Why?
Young Adult
7
2018
4337
0.240
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
582
0.230
 Why?
Gene Rearrangement
1
2025
76
0.220
 Why?
Chromosome Aberrations
1
2006
297
0.220
 Why?
HSP70 Heat-Shock Proteins
1
2004
71
0.220
 Why?
Receptors, Androgen
1
2024
47
0.210
 Why?
Receptors, Progesterone
1
2024
66
0.210
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.210
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.210
 Why?
Quinazolines
1
2003
32
0.210
 Why?
Oncostatin M
2
2021
5
0.210
 Why?
Antigens, Neoplasm
1
2004
147
0.210
 Why?
Polymorphism, Genetic
5
2018
184
0.210
 Why?
Genome-Wide Association Study
2
2017
187
0.200
 Why?
Small Cell Lung Carcinoma
1
2023
30
0.200
 Why?
Omentum
1
2002
16
0.200
 Why?
Case-Control Studies
7
2019
1202
0.200
 Why?
Chromosome Deletion
3
2000
141
0.200
 Why?
Treatment Outcome
23
2014
5486
0.200
 Why?
Linkage Disequilibrium
3
2017
40
0.190
 Why?
Neoadjuvant Therapy
2
2022
125
0.190
 Why?
Proto-Oncogene Proteins c-akt
2
2014
172
0.190
 Why?
Genetic Variation
4
2019
230
0.190
 Why?
Tumor Microenvironment
2
2021
255
0.190
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.190
 Why?
CA-125 Antigen
3
2008
16
0.190
 Why?
Antibodies, Monoclonal, Humanized
5
2013
237
0.190
 Why?
Base Pair Mismatch
5
2006
21
0.190
 Why?
Suction
1
2001
23
0.190
 Why?
Chemoradiotherapy
1
2022
50
0.190
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.180
 Why?
Postoperative Complications
3
2022
1081
0.180
 Why?
Smoking
1
2005
518
0.180
 Why?
Radiotherapy, Conformal
2
2014
53
0.180
 Why?
Proteins
5
2008
354
0.180
 Why?
Carcinoma in Situ
2
2013
72
0.180
 Why?
Adaptor Proteins, Signal Transducing
8
2007
201
0.180
 Why?
Antimetabolites, Antineoplastic
2
2002
38
0.170
 Why?
Gene Regulatory Networks
2
2019
111
0.170
 Why?
Fetofetal Transfusion
1
2020
6
0.170
 Why?
Polycythemia
1
2020
9
0.170
 Why?
Pregnancy, Twin
1
2020
8
0.170
 Why?
Minority Groups
1
2022
135
0.170
 Why?
Radiotherapy
3
2010
129
0.170
 Why?
Twins, Monozygotic
1
2020
16
0.170
 Why?
Colorectal Neoplasms
3
2002
295
0.170
 Why?
Lymph Node Excision
7
2019
133
0.170
 Why?
Sarcoma
3
2009
70
0.170
 Why?
Genetic Diseases, Inborn
1
2000
24
0.170
 Why?
Patient Satisfaction
2
2006
284
0.170
 Why?
Receptor, erbB-3
1
2020
2
0.170
 Why?
Furin
1
2020
3
0.170
 Why?
HLA-DQ Antigens
1
2000
3
0.170
 Why?
Phosphoproteins
2
2016
122
0.170
 Why?
Receptor, IGF Type 1
1
2020
22
0.160
 Why?
Transcriptome
2
2020
368
0.160
 Why?
Mice, Nude
4
2021
235
0.160
 Why?
Tomography, X-Ray Computed
7
2013
1162
0.160
 Why?
Tumor Cells, Cultured
7
2021
448
0.160
 Why?
Prenatal Diagnosis
1
2020
103
0.160
 Why?
RNA, Neoplasm
3
2007
45
0.160
 Why?
Antibodies, Neoplasm
1
2019
27
0.160
 Why?
Students
1
2022
228
0.160
 Why?
Papillomavirus E7 Proteins
2
2017
32
0.160
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.160
 Why?
Adolescent
13
2018
6737
0.160
 Why?
Reproducibility of Results
2
2022
1217
0.150
 Why?
Placenta
1
2020
153
0.150
 Why?
Indocyanine Green
1
2019
29
0.150
 Why?
Follow-Up Studies
13
2019
2291
0.150
 Why?
Doxorubicin
4
2009
241
0.150
 Why?
Fallopian Tube Neoplasms
3
2008
15
0.150
 Why?
Decision Making
1
2001
282
0.150
 Why?
Salvage Therapy
3
2008
136
0.150
 Why?
Cyclooxygenase 2
2
2017
50
0.140
 Why?
Sequence Analysis, DNA
1
2019
230
0.140
 Why?
Transcription Factors
1
2021
566
0.140
 Why?
HLA-DRB1 Chains
1
2017
5
0.140
 Why?
HLA-B Antigens
1
2017
8
0.140
 Why?
Lung Neoplasms
2
2023
634
0.140
 Why?
Metabolic Networks and Pathways
1
2018
93
0.140
 Why?
DNA Copy Number Variations
1
2018
117
0.140
 Why?
Receptors, Vitronectin
1
1997
1
0.140
 Why?
Proto-Oncogene Proteins
5
2004
151
0.140
 Why?
Tumor Suppressor Proteins
3
2005
128
0.140
 Why?
Carcinoma, Adenosquamous
3
2009
9
0.140
 Why?
DNA Mutational Analysis
9
2005
180
0.140
 Why?
Interleukin-10
1
2017
84
0.140
 Why?
Bayes Theorem
1
2017
120
0.130
 Why?
In Situ Hybridization
3
2008
68
0.130
 Why?
Leukocytes, Mononuclear
1
2017
122
0.130
 Why?
Animals
11
2021
13507
0.130
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
22
0.130
 Why?
Protein Binding
1
2019
673
0.130
 Why?
Adipose Tissue
1
2019
204
0.130
 Why?
Radiotherapy, Intensity-Modulated
2
2009
182
0.130
 Why?
Gene Expression Regulation, Viral
1
2017
49
0.130
 Why?
Risk Assessment
9
2019
1350
0.130
 Why?
Radiotherapy Dosage
8
2014
253
0.130
 Why?
Body Mass Index
3
2010
692
0.130
 Why?
Radiation Injuries
3
2008
110
0.130
 Why?
Diagnosis, Differential
4
2024
1048
0.130
 Why?
ROC Curve
1
2017
254
0.130
 Why?
Taxoids
3
2006
38
0.130
 Why?
Biopsy
5
2006
607
0.120
 Why?
Cells, Cultured
3
2017
1588
0.120
 Why?
Carrier Proteins
7
2006
320
0.120
 Why?
Estrogens
1
2017
223
0.120
 Why?
Prospective Studies
10
2019
2457
0.120
 Why?
Colposcopy
3
2006
17
0.120
 Why?
Molecular Sequence Data
5
2009
773
0.120
 Why?
Mice
7
2021
5958
0.120
 Why?
Wound Healing
2
2018
219
0.120
 Why?
Carcinosarcoma
3
2019
18
0.120
 Why?
Apoptosis
2
2021
1121
0.120
 Why?
Double-Blind Method
1
2017
718
0.120
 Why?
Sensitivity and Specificity
4
2006
883
0.120
 Why?
Ultrasonography, Doppler, Color
1
1995
33
0.120
 Why?
Dose-Response Relationship, Drug
6
2008
1378
0.120
 Why?
Aneurysm
1
1995
31
0.120
 Why?
Algorithms
1
2019
668
0.120
 Why?
DNA Primers
2
2006
206
0.110
 Why?
Protein Kinase Inhibitors
2
2014
228
0.110
 Why?
Platinum Compounds
4
2008
11
0.110
 Why?
Phosphatidylinositol 3-Kinases
2
2014
150
0.110
 Why?
Obesity
5
2010
1165
0.110
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
5
0.110
 Why?
Cyclohexanones
1
2014
5
0.110
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.110
 Why?
Embolization, Therapeutic
1
1995
88
0.110
 Why?
Camptothecin
3
2010
14
0.110
 Why?
Transcriptional Activation
2
2019
128
0.110
 Why?
TOR Serine-Threonine Kinases
1
2014
82
0.110
 Why?
Genetic Association Studies
1
2014
124
0.110
 Why?
Introns
1
2013
54
0.100
 Why?
Hypercalcemia
1
1993
34
0.100
 Why?
Paclitaxel
4
2007
91
0.100
 Why?
Decision Support Techniques
2
2010
71
0.100
 Why?
Chromosome Mapping
3
2005
151
0.100
 Why?
Cell Transformation, Neoplastic
2
2006
184
0.100
 Why?
Pyridines
1
2014
134
0.100
 Why?
Brain Neoplasms
1
2016
290
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
35
0.100
 Why?
Models, Genetic
1
2012
172
0.100
 Why?
Tomography, Emission-Computed
4
2005
53
0.100
 Why?
Groin
2
2002
16
0.090
 Why?
Keratinocytes
2
2006
93
0.090
 Why?
Laser Therapy
1
1992
76
0.090
 Why?
RNA, Messenger
4
2021
1139
0.090
 Why?
Glucose
1
2014
358
0.090
 Why?
Cystadenocarcinoma, Serous
2
2024
73
0.090
 Why?
Exons
3
2007
101
0.090
 Why?
Pyrazoles
2
2023
114
0.090
 Why?
Infusions, Intravenous
4
2006
222
0.090
 Why?
Magnetic Resonance Imaging
3
2014
1545
0.090
 Why?
Heterozygote
2
2004
91
0.090
 Why?
Condylomata Acuminata
1
1991
4
0.090
 Why?
Models, Statistical
1
2012
231
0.090
 Why?
Epithelium
2
2007
65
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
22
0.090
 Why?
Estrogen Antagonists
1
2010
21
0.090
 Why?
Ileal Diseases
1
1990
4
0.090
 Why?
Predictive Value of Tests
6
2010
952
0.090
 Why?
Leiomyoma
1
1990
23
0.090
 Why?
Cell Differentiation
2
2009
673
0.080
 Why?
Polymorphism, Restriction Fragment Length
1
2010
66
0.080
 Why?
Restriction Mapping
3
2006
33
0.080
 Why?
Epigenesis, Genetic
2
2019
407
0.080
 Why?
Colonic Neoplasms
2
2004
163
0.080
 Why?
Gastrointestinal Hemorrhage
1
1990
90
0.080
 Why?
Skin Transplantation
1
1990
44
0.080
 Why?
Down-Regulation
4
2020
344
0.080
 Why?
Age Factors
4
2006
1132
0.080
 Why?
Fluorouracil
2
2006
59
0.080
 Why?
Maximum Tolerated Dose
5
2010
39
0.080
 Why?
Endometrium
3
2019
43
0.080
 Why?
Urinary Bladder Diseases
1
2009
18
0.080
 Why?
Intestinal Diseases
1
2009
26
0.080
 Why?
Lymphatic Vessels
1
2009
44
0.080
 Why?
Lasers, Gas
1
2009
6
0.080
 Why?
Embolism, Air
1
2009
10
0.080
 Why?
Transcription, Genetic
4
2019
380
0.080
 Why?
Vaginal Neoplasms
2
2005
5
0.080
 Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
 Why?
Fluorine Radioisotopes
1
2008
25
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
 Why?
Infertility, Female
1
2008
19
0.070
 Why?
Eimeria
1
2008
3
0.070
 Why?
Polyethylene Glycols
2
2006
90
0.070
 Why?
Haplotypes
2
2017
94
0.070
 Why?
Up-Regulation
2
2020
462
0.070
 Why?
Cell Cycle Proteins
1
2009
170
0.070
 Why?
Angiogenesis Inhibitors
2
2006
184
0.070
 Why?
Ubiquitin
1
2008
68
0.070
 Why?
Cricetinae
1
2008
193
0.070
 Why?
Tumor Burden
2
2021
136
0.070
 Why?
Expressed Sequence Tags
1
2007
6
0.070
 Why?
Diagnostic Imaging
1
2009
173
0.070
 Why?
Infusion Pumps
1
1987
13
0.070
 Why?
Fluorescent Antibody Technique
1
2007
111
0.070
 Why?
Microdissection
1
2007
20
0.070
 Why?
Models, Biological
2
2008
741
0.070
 Why?
Precancerous Conditions
2
2005
85
0.070
 Why?
Lasers
1
2007
65
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Stromal Cells
1
2007
77
0.070
 Why?
Organ Specificity
2
2018
117
0.070
 Why?
Aorta
3
2005
170
0.070
 Why?
Codon
2
2003
43
0.070
 Why?
Pelvic Floor
1
2007
52
0.070
 Why?
Neutropenia
1
2007
115
0.070
 Why?
Recombinant Proteins
1
2008
496
0.070
 Why?
RNA, Double-Stranded
1
2006
23
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
19
0.060
 Why?
Tissue Fixation
1
2006
36
0.060
 Why?
Intestinal Perforation
2
2006
24
0.060
 Why?
Pulmonary Embolism
1
1987
85
0.060
 Why?
Specimen Handling
1
2006
56
0.060
 Why?
Head and Neck Neoplasms
2
2016
287
0.060
 Why?
Protein Kinases
1
2006
74
0.060
 Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Abdomen
1
2006
73
0.060
 Why?
Proportional Hazards Models
4
2010
444
0.060
 Why?
Papillomavirus Vaccines
1
2006
69
0.060
 Why?
Neovascularization, Pathologic
1
2006
158
0.060
 Why?
Recurrence
4
2010
683
0.060
 Why?
Probability
4
2007
173
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Terminal Care
1
2005
48
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
52
0.060
 Why?
Cell Adhesion Molecules
1
2005
88
0.060
 Why?
Quinolines
1
2004
44
0.060
 Why?
Male
11
2018
26863
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
224
0.060
 Why?
Amyloid
1
2004
36
0.050
 Why?
Tissue Distribution
1
2004
173
0.050
 Why?
Genes, Viral
1
2003
39
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
237
0.050
 Why?
Lactones
1
2003
25
0.050
 Why?
Abdomen, Acute
1
2003
6
0.050
 Why?
Biopsy, Needle
4
2006
182
0.050
 Why?
Thrombospondins
1
2003
10
0.050
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
58
0.050
 Why?
Pyrimidinones
1
2023
19
0.050
 Why?
RNA, Viral
2
2016
125
0.050
 Why?
Obesity, Morbid
1
2004
89
0.050
 Why?
Clinical Competence
1
2006
404
0.050
 Why?
Fibroma
1
2003
40
0.050
 Why?
Neoplasms, Second Primary
1
2004
77
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
64
0.050
 Why?
Congenital Abnormalities
1
2004
118
0.050
 Why?
Uterine Hemorrhage
1
2002
11
0.050
 Why?
Age of Onset
2
2004
110
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
PTEN Phosphohydrolase
2
2019
55
0.050
 Why?
DNA, Ribosomal
1
2002
26
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
336
0.050
 Why?
Blood Transfusion, Autologous
1
2002
4
0.050
 Why?
Genital Diseases, Female
1
2002
17
0.050
 Why?
Blood Donors
1
2002
21
0.050
 Why?
Pregnancy
3
2020
2679
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Postmenopause
1
2002
81
0.050
 Why?
Medical History Taking
1
2002
47
0.050
 Why?
Medical Records
1
2002
87
0.050
 Why?
Complementary Therapies
1
2002
23
0.050
 Why?
Family Health
1
2002
79
0.050
 Why?
AU Rich Elements
1
2021
2
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
 Why?
RNA Stability
1
2021
25
0.050
 Why?
Cytokine Receptor gp130
1
2021
14
0.050
 Why?
3' Untranslated Regions
1
2021
55
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
29
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.040
 Why?
Blotting, Northern
2
2001
109
0.040
 Why?
Diet Records
1
2001
18
0.040
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
25
0.040
 Why?
Blotting, Southern
3
2002
42
0.040
 Why?
Internship and Residency
1
2006
449
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
222
0.040
 Why?
Phosphoric Monoester Hydrolases
1
2000
23
0.040
 Why?
Equipment Design
1
2001
288
0.040
 Why?
Blood Vessels
1
2001
72
0.040
 Why?
Catheterization, Central Venous
1
2001
82
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Nutrition Assessment
1
2001
66
0.040
 Why?
Isoenzymes
1
2001
167
0.040
 Why?
Logistic Models
2
2017
934
0.040
 Why?
Risk Management
1
2000
31
0.040
 Why?
Physical Chromosome Mapping
1
2000
7
0.040
 Why?
Quality Improvement
1
2022
224
0.040
 Why?
Incidence
3
2007
1077
0.040
 Why?
Dietary Fats
1
2001
129
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Patient Discharge
1
2022
326
0.040
 Why?
Interviews as Topic
1
2001
274
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
 Why?
Cell Survival
1
2021
602
0.040
 Why?
DNA Repair Enzymes
1
1999
43
0.040
 Why?
Adenosine Triphosphatases
1
1999
91
0.040
 Why?
Cell Nucleus
1
2019
189
0.040
 Why?
Regression Analysis
3
2006
403
0.040
 Why?
Cross-Sectional Studies
1
2024
1686
0.040
 Why?
Coloring Agents
1
2019
68
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Molecular Targeted Therapy
1
2019
134
0.040
 Why?
Pregnancy Outcome
1
2020
250
0.040
 Why?
Gene Dosage
1
2018
78
0.040
 Why?
Histone Demethylases
1
2018
19
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Leptin
1
2019
148
0.040
 Why?
Estradiol
1
2019
216
0.040
 Why?
Databases, Genetic
1
2018
83
0.030
 Why?
Major Histocompatibility Complex
1
2017
13
0.030
 Why?
Genotyping Techniques
1
2017
20
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2018
58
0.030
 Why?
Chemokines
1
2017
79
0.030
 Why?
Receptors, Collagen
1
1997
3
0.030
 Why?
Receptors, Fibronectin
1
1997
5
0.030
 Why?
Mass Screening
1
2000
358
0.030
 Why?
Coculture Techniques
1
2017
145
0.030
 Why?
Time Factors
4
2010
3000
0.030
 Why?
Child
4
2018
7229
0.030
 Why?
Interferon-gamma
1
2018
179
0.030
 Why?
Transforming Growth Factor beta
1
2018
140
0.030
 Why?
Integrins
1
1997
31
0.030
 Why?
Chemotherapy, Adjuvant
2
2010
124
0.030
 Why?
Quality-Adjusted Life Years
2
2010
67
0.030
 Why?
Diet, High-Fat
1
2019
237
0.030
 Why?
Epithelial Cells
2
2006
215
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Longitudinal Studies
1
2019
747
0.030
 Why?
Herpesviridae
1
2016
19
0.030
 Why?
Viruses
1
2016
24
0.030
 Why?
Host-Pathogen Interactions
1
2017
144
0.030
 Why?
Mice, Transgenic
1
2017
564
0.030
 Why?
Pilot Projects
3
2004
721
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
42
0.030
 Why?
Cost-Benefit Analysis
2
2010
269
0.030
 Why?
DNA Replication
1
1997
160
0.030
 Why?
Baths
1
1995
5
0.030
 Why?
Plasmids
2
2001
167
0.030
 Why?
Sequence Analysis, RNA
1
2016
99
0.030
 Why?
Central Nervous System Neoplasms
1
2016
69
0.030
 Why?
Fibroblasts
1
2017
359
0.030
 Why?
Electrosurgery
1
1995
9
0.030
 Why?
Macrophages
1
2018
379
0.030
 Why?
Prostatic Neoplasms
1
1998
400
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
CpG Islands
2
2008
121
0.030
 Why?
Computational Biology
1
2016
211
0.030
 Why?
Arteries
1
1995
94
0.030
 Why?
Cytokines
1
2017
626
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
 Why?
Multivariate Analysis
2
2009
602
0.030
 Why?
Treatment Failure
2
2008
122
0.030
 Why?
Dementia
1
1995
134
0.030
 Why?
Missouri
2
2006
66
0.030
 Why?
Organs at Risk
1
2014
73
0.030
 Why?
Inclusion Bodies
1
1993
17
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
24
0.030
 Why?
Cell Division
2
1994
288
0.030
 Why?
Cell Death
1
2014
175
0.030
 Why?
Cholera Toxin
1
1993
16
0.030
 Why?
Cholera
1
1993
2
0.030
 Why?
Imaging, Three-Dimensional
1
2014
151
0.030
 Why?
Risk
2
2004
313
0.030
 Why?
Skin Physiological Phenomena
1
1992
15
0.020
 Why?
Guinea Pigs
1
1992
75
0.020
 Why?
Pelvis
2
2004
67
0.020
 Why?
Epidermis
1
1992
32
0.020
 Why?
Pedigree
2
2004
126
0.020
 Why?
Deoxyglucose
1
2012
35
0.020
 Why?
Regeneration
1
1992
79
0.020
 Why?
Colectomy
1
1992
35
0.020
 Why?
Computer Simulation
1
2012
290
0.020
 Why?
Sequence Deletion
2
2003
72
0.020
 Why?
Premenopause
1
2010
27
0.020
 Why?
Amino Acid Sequence
2
2003
574
0.020
 Why?
Staurosporine
1
2010
10
0.020
 Why?
Anastomosis, Surgical
1
1990
70
0.020
 Why?
Molecular Weight
1
1990
80
0.020
 Why?
Remission Induction
1
2010
219
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
69
0.020
 Why?
ras Proteins
2
2001
64
0.020
 Why?
Cicatrix
1
1990
42
0.020
 Why?
Staining and Labeling
1
1990
92
0.020
 Why?
Hemoglobins
1
1990
111
0.020
 Why?
Chi-Square Distribution
1
2010
295
0.020
 Why?
Perioperative Care
1
2009
43
0.020
 Why?
Fetus
1
1990
195
0.020
 Why?
Urinary Incontinence
1
2009
40
0.020
 Why?
Organoplatinum Compounds
1
2008
14
0.020
 Why?
Gene Knockdown Techniques
1
2009
110
0.020
 Why?
Vinblastine
1
2008
22
0.020
 Why?
Life Style
1
2009
145
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
183
0.020
 Why?
Emotions
1
2009
174
0.020
 Why?
Cadherins
1
2007
63
0.020
 Why?
Demography
1
2007
92
0.020
 Why?
Cell Line
1
1990
1033
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
137
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
Skin
1
1990
418
0.020
 Why?
DNA Mismatch Repair
1
2006
18
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
17
0.020
 Why?
Waxes
1
2006
2
0.020
 Why?
NIH 3T3 Cells
1
2006
52
0.020
 Why?
Immunoenzyme Techniques
2
2001
136
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
11
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
173
0.020
 Why?
Cryopreservation
1
2006
41
0.020
 Why?
Analysis of Variance
1
2007
558
0.020
 Why?
Transfection
1
2006
369
0.020
 Why?
Mutation, Missense
1
2006
108
0.020
 Why?
Gene Expression
1
2008
623
0.020
 Why?
Nurse Practitioners
1
2006
44
0.020
 Why?
Gynecology
1
2006
52
0.020
 Why?
Early Diagnosis
1
2006
87
0.020
 Why?
Medical Futility
1
2005
8
0.020
 Why?
Ovarian Cysts
1
2005
4
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Cyclophosphamide
1
2006
172
0.020
 Why?
Triage
1
2006
66
0.020
 Why?
Leiomyosarcoma
1
2005
22
0.010
 Why?
Hospice Care
1
2005
26
0.010
 Why?
Cytodiagnosis
1
2005
43
0.010
 Why?
Health Services
1
2005
66
0.010
 Why?
Phosphorylation
1
2006
530
0.010
 Why?
Obstetrics
1
2006
89
0.010
 Why?
Lymphatic System
1
2004
12
0.010
 Why?
Penetrance
1
2004
7
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
70
0.010
 Why?
Area Under Curve
1
2004
183
0.010
 Why?
Calcification, Physiologic
1
2004
42
0.010
 Why?
Laparotomy
1
2004
37
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
17
0.010
 Why?
Ethanol
1
2006
343
0.010
 Why?
Genomic Instability
1
2004
89
0.010
 Why?
Tamoxifen
1
2004
59
0.010
 Why?
Thrombospondin 1
1
2003
9
0.010
 Why?
Genes, p16
1
2003
9
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Confidence Intervals
1
2003
159
0.010
 Why?
Frameshift Mutation
1
2003
18
0.010
 Why?
Liposomes
1
2003
53
0.010
 Why?
Administration, Oral
1
2004
455
0.010
 Why?
Mutagenesis, Insertional
1
2003
24
0.010
 Why?
Body Weight
1
2005
523
0.010
 Why?
Palliative Care
1
2005
216
0.010
 Why?
Cytoskeletal Proteins
1
2003
48
0.010
 Why?
Physicians
1
2006
241
0.010
 Why?
DNA Transposable Elements
1
2003
107
0.010
 Why?
Prevalence
1
2006
1017
0.010
 Why?
Reference Values
1
2003
313
0.010
 Why?
beta Catenin
1
2003
103
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
Retinoblastoma Protein
1
2002
19
0.010
 Why?
Ifosfamide
1
2002
9
0.010
 Why?
Documentation
1
2002
33
0.010
 Why?
Trans-Activators
1
2003
138
0.010
 Why?
Bleomycin
1
2002
38
0.010
 Why?
Hospitals, University
1
2002
75
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
77
0.010
 Why?
Equipment Failure
1
2001
64
0.010
 Why?
Age Distribution
1
2002
175
0.010
 Why?
Statistics, Nonparametric
1
2002
196
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
79
0.010
 Why?
Nucleic Acid Hybridization
2
1991
55
0.010
 Why?
Carcinoma, Small Cell
1
2001
26
0.010
 Why?
Radiography
1
2002
474
0.010
 Why?
Genes, erbB-1
1
2001
9
0.010
 Why?
Outpatients
1
2002
126
0.010
 Why?
Hospitalization
1
2005
749
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
90
0.010
 Why?
DNA
1
2004
549
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
155
0.010
 Why?
Genetic Linkage
1
2000
25
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
 Why?
Morbidity
1
2000
143
0.010
 Why?
Blotting, Western
1
2001
593
0.010
 Why?
Gene Deletion
1
2000
275
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
169
0.010
 Why?
Chromosomes, Bacterial
1
1998
5
0.010
 Why?
Cloning, Molecular
1
1998
182
0.010
 Why?
Infant
1
2006
3720
0.010
 Why?
Child, Preschool
1
2006
4062
0.010
 Why?
Drug Resistance, Multiple
1
1997
24
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
70
0.010
 Why?
Gene Frequency
1
1997
99
0.010
 Why?
United States
1
2007
5227
0.010
 Why?
Hygiene
1
1995
11
0.010
 Why?
Guidelines as Topic
1
1995
110
0.010
 Why?
Dimethyl Sulfoxide
1
1994
12
0.010
 Why?
Glycerol
1
1994
19
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
52
0.010
 Why?
Drug Carriers
1
1994
68
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
136
0.010
 Why?
Cell Cycle
1
1994
240
0.010
 Why?
H-2 Antigens
1
1993
3
0.010
 Why?
Caregivers
1
1995
238
0.010
 Why?
Cell Line, Transformed
1
1993
74
0.010
 Why?
Mice, Inbred Strains
1
1993
164
0.010
 Why?
Retroperitoneal Space
1
1991
26
0.010
 Why?
Disease Models, Animal
1
1993
1486
0.000
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (647) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department